Page 251 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 251

230   PART III    Therapeutic Modalities for the Cancer Patient


           239.   Pack L, Roberts RE, Dawson SD, et al.: Definitive radiation ther-    243.   Fuccio L, Guido A, Laterza L, et al.: Randomised clinical trial: pre-
              apy for infiltrative thyroid carcinoma in dogs, Vet Radiol Ultrasound   ventive treatment with topical rectal beclomethasone dipropionate
              42:471–474, 2001.                                     reduces  post-radiation  risk  of  bleeding  in  patients  irradiated for
  VetBooks.ir    240.   Ohara K, Tatsuzaki H, Fuji H, et al.: Radioresponse of thymomas     244.   Magestro LM, Gieger TL, Nolan MW: Stereotactic body radiation
                                                                    prostate cancer, Aliment Pharmacol Ther 34:628–637, 2011.
              verified with histologic response, Acta Oncol 37:471–474, 1998.
           241.   Smith AN, Wright JC, Brawner Jr WR, et al.: Radiation therapy in
                                                                    197, 2018.
              the treatment of canine and feline thymomas: a retrospective study   therapy for heart-base tumors in six dogs, J Vet Cardiol 20:186–
              (1985-1999), J Am Anim Hosp Assoc 37:489–496, 2001.
           242.   Meier V, Besserer J, Roos M, et  al.: A complication  probability
              study for a definitive-intent, moderately hypofractionated image-
              guided intensity-modulated radiotherapy protocol for anal sac ade-
              nocarcinoma in dogs, Vet Comp Oncol 218; epub ahead of print.
              DOI: 10.1111/vco.12441
   246   247   248   249   250   251   252   253   254   255   256